Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Transplant International : Official Journal of the European Society for Organ Transplantation|October 24, 2017
Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort studySimon Ville, Berthe-Marie Imbert-Marcille, Marianne Coste-Burel, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|February 23, 2023
Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant RecipientsChristophe Masset, Clarisse Kerleau, Gilles Blancho, et al.Frontiers in Immunology|September 26, 2019
CXCR5<sup>+</sup>PD1<sup>+</sup>ICOS<sup>+</sup> Circulating T Follicular Helpers Are Associated With <i>de novo</i> Donor-Specific Antibodies After Renal TransplantationRichard Danger, Mélanie Chesneau, Florent Delbos, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 2021
Clinical utility of C-peptide measurement after pancreas transplantation with especial focus on early graft thrombosisChristophe Masset, Julien Branchereau, Georges Karam, et al.Mabs|March 7, 2014
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, et al.Journal of Clinical Medicine|June 10, 2022
Time-Limited Therapy with Belatacept in Kidney Transplant RecipientsThibault Letellier, Delphine Kervella, Abderrahmane Sadek, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2025
Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post-C5 inhibitor eraLéo Drapeau, Jean Paraire, Mehdi Maanaoui, et al.Kidney International Reports|May 2, 2022
Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKDCharles Ronsin, Anis Chaba, Ondrej Suchanek, et al.Iscience|September 2, 2025
MEK inhibition prevents human skin graft rejection by promoting CD8<sup>+</sup>TCF1<sup>+</sup> over CD8 effector T cellsChristine Chauveau, Veronique Nerriere-Daguin, Maeva Fourny, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2015
Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman PrimatesNicolas Poirier, Melanie Chevalier, Caroline Mary, et al.Pageof 5